Lantern Pharma Inc (LTRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 3,508 | 3,405 | 4,203 | 4,350 | 4,652 |
| Operating Income | -3,508 | -3,405 | -4,203 | -4,350 | -4,652 |
| Other Income | -3,564 | 76 | 129 | 172 | 321 |
| Pre-tax Income | -7,072 | -3,329 | -4,074 | -4,177 | -4,331 |
| Net Income Continuous | -7,072 | -3,329 | -4,074 | -4,177 | -4,331 |
| Net Income | $-7,072 | $-3,329 | $-4,074 | $-4,177 | $-4,331 |
| EPS Basic Total Ops | -0.57 | -0.30 | -0.36 | -0.39 | -0.40 |
| EPS Basic Continuous Ops | -0.57 | -0.30 | -0.36 | -0.39 | -0.40 |
| EPS Diluted Total Ops | -0.57 | -0.30 | -0.36 | -0.39 | -0.40 |
| EPS Diluted Continuous Ops | -0.57 | -0.30 | -0.36 | -0.39 | -0.40 |
| EPS Diluted Before Non-Recurring Items | -0.28 | -0.30 | -0.36 | -0.39 | -0.40 |
| EBITDA(a) | $-3,504 | $-3,401 | $-4,224 | $-4,517 | $-4,647 |